Clinical Trial Update: Evaluation of Woulgan in Diabetic Foot Ulcer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Woulgan for diabetic foot ulcers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Woulgan

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Diabetic Foot Ulcers | Phase 4 | Status: COMPLETED